AU8845282A - Alpha-(aminomethyl) 1h-indol-4-methanol derivatives - Google Patents
Alpha-(aminomethyl) 1h-indol-4-methanol derivativesInfo
- Publication number
- AU8845282A AU8845282A AU88452/82A AU8845282A AU8845282A AU 8845282 A AU8845282 A AU 8845282A AU 88452/82 A AU88452/82 A AU 88452/82A AU 8845282 A AU8845282 A AU 8845282A AU 8845282 A AU8845282 A AU 8845282A
- Authority
- AU
- Australia
- Prior art keywords
- formula
- product
- see diagramm
- already indicated
- significance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BVSGXWCTWBZFEV-UHFFFAOYSA-N 1h-indol-4-ylmethanol Chemical class OCC1=CC=CC2=C1C=CN2 BVSGXWCTWBZFEV-UHFFFAOYSA-N 0.000 title 1
- -1 aminomethyl 1H-indol-4-methanol Chemical compound 0.000 abstract 20
- 125000004432 carbon atom Chemical group C* 0.000 abstract 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 4
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 4
- 239000003638 chemical reducing agent Substances 0.000 abstract 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 2
- 229910052801 chlorine Inorganic materials 0.000 abstract 2
- 239000000460 chlorine Substances 0.000 abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 2
- 229910052740 iodine Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 239000011707 mineral Substances 0.000 abstract 2
- 150000007522 mineralic acids Chemical class 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 235000005985 organic acids Nutrition 0.000 abstract 2
- DITHIFQMPPCBCU-UHFFFAOYSA-N propa-1,2-diene Chemical compound [CH]=C=C DITHIFQMPPCBCU-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000011987 methylation Effects 0.000 abstract 1
- 238000007069 methylation reaction Methods 0.000 abstract 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Derivates of aminomethyl 1H-indol-4-methanol as well as their salts of addition with mineral or organic acids, characterized in that they answer to the general formula I : see diagramm : EP0076713,P28,F1 in which R represents a hydrogen atom, or an alkyl radical containing from 1 to 6 carbon atoms or a phenyl alkyl radical containing from 7 to 10 carbon atoms and R1 and R2 , being identical or different, each represents a hydrogen atom, a linear or branched alkyl radical containing from 1 to 8 carbon atoms, possibly substituted, except in the case of the methyl radical, by one or more halogen atoms or by one or more hydroxy, phenyl or phenoxy radicals themselves possibly substituted by one or more halogen atoms or by one or more hydroxy, methyl, methoxy or acetamido radicals, R1 and R2 can also represent a cycloalkyl radical containing from 3 to 7 carbon atoms, a cycloalkylalkyl radical containing from 4 to 7 carbon atoms or an allyl or propargyl radical and the dotted line represents the possible presence of a carbon-carbon bond. 1. Claims for the Contracting State : AT Process for preparing derivatives of aminomethyl 1H-indol-4-methanol as well as their salts of addition with mineral or organic acids, answering to the general formula I : see diagramm : EP0076713,P31,F2 in which R represents a hydrogen atom, or an alkyl radical containing from 1 to 6 carbon atoms or a phenyl alkyl radical containing from 7 to 10 carbon atoms and R1 and R2 , being identical or different, each represent a hydrogen atom, a linear or branched alkyl radical containing from 1 to 8 carbon atoms, possibly substituted, except in the case of the methyl radical, by one or more halogen atoms or by one or more hydroxy, phenyl or phenoxy radicals themselves possibly substituted by one or more halogen atoms or by one or more hydroxy, methyl, methoxy or acetamido radicals, R1 and R2 can also represent a cycloalkyl radical containing from 3 to 7 carbon atoms, a cycloalkylalkyl radical containing from 4 to 7 carbon atoms or an allyl or propargyl radical and the dotted line represents the possible presence of a carbon-carbon bond, characterized in that a product with the formula II : see diagramm : EP0076713,P31,F4 in which R has the significance already indicated, is made to react with trimethyl silyl cyanide, so as to obtain a product with the formula III : see diagramm : EP0076713,P31,F5 in which R has the significance already indicated, which is reduced, so as to obtain a product with the formula IA : see diagramm : EP0076713,P32,F1 in which R has the significance already indicated which : either is isolated, and if desired, is salified, or the said product with the formula IA is made to react with a carbonyl derivative with the formula IV : see diagramm : EP0076713,P32,F3 in which R alpha and R beta are such that : see diagramm : EP0076713,P32,F5 has the significance of R1 already indicated with the exception of a hydrogen atom and a methyl radical, in the presence of a reducing agent, so as to obtain a product with the formula IB : see diagramm : EP0076713,P32,F7 or I'B see diagramm : EP0076713,P32,F9 in which R, R alpha and R beta have the significance already indicated, which product with the formula IB or I'B is isolated and if desired, salified or which product with the formula IB is submitted to the action of a halogenide with the formula V : X-R'2 in which X represents a chlorine, bromine or iodine atom, and R'2 has the significance of R2 already indicated with the exception of hydrogen, so as to obtain a product with the formula IC : see diagramm : EP0076713,P32,F2 in which R, R alpha, R beta and R'2 have the significance already indicated which is isolated and if desired, salified, or the said product with the formula IA is made to react with a carbonyl derivative with the formula IVa : see diagramm : EP0076713,P32,F4 in which Hal represents a chlorine, bromine or iodine atom, and see diagramm : EP0076713,P32,F6 is such that -CH2 -R'1 has the significance of R1 already indicated, with the exception of a hydrogen atom and of the methyl radical, then the derivative obtained is submitted to the action of a reducing agent, so as to obtain a product with the formula ID : see diagramm : EP0076713,P32,F8 in which R and R'1 have the significance already indicated, which product with the formula ID is either isolated and if desired, salified, or is submitted to the action of a halogenide with the formula V : X-R'2 in which X and R'2 have the significance already indicated, so as to obtain a product with the formula IE : see diagramm : EP0076713,P32,F10 in which R, R'1 and R'2 have the significance already indicated, which is isolated, and if desired, salified, or the said product with the formula IA is submitted to methylation, so as to obtain a product with the formula IF : see diagramm : EP0076713,P33,F2 in which R has the significance already indicated, which is either isolated, and if desired, salified, or is made to react with a halogenide with the formula V defined above, so as to obtain a product with the formula IG : see diagramm : EP0076713,P33,F4 in which R and R'2 have the significance already indicated, which is isolated and if desired, salified, and if desired, the said products with the formulae IA , IB , I'B , IC , ID , IE , IF and IG , are submitted to the action of a reducing agent of the indole nucleus, so as to obtain a product with the formula I' : see diagramm : EP0076713,P33,F7 in which R, R1 and R2 have the significance already indicated, which is isolated, and if desired, salified.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8117560 | 1981-09-17 | ||
| FR8117560A FR2512817A1 (en) | 1981-09-17 | 1981-09-17 | NOVEL AMINOMETHYL 1H-INDOLE-4-METHANOL DERIVATIVES AND THEIR SALTS, PROCESS FOR PREPARING THEM, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS COMPRISING THEM AND THEIR PREPARATION INTERMEDIATES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8845282A true AU8845282A (en) | 1983-03-24 |
| AU550238B2 AU550238B2 (en) | 1986-03-13 |
Family
ID=9262232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU88452/82A Ceased AU550238B2 (en) | 1981-09-17 | 1982-09-16 | Alpha-(aminomethyl) 1h-indol-4-methanol derivatives |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0076713B1 (en) |
| JP (1) | JPS5862161A (en) |
| AT (1) | ATE17347T1 (en) |
| AU (1) | AU550238B2 (en) |
| CA (1) | CA1200554A (en) |
| DE (1) | DE3268423D1 (en) |
| DK (1) | DK413482A (en) |
| ES (2) | ES8401463A1 (en) |
| FI (1) | FI77444C (en) |
| FR (1) | FR2512817A1 (en) |
| HU (1) | HU189177B (en) |
| IE (1) | IE54262B1 (en) |
| PT (1) | PT75565B (en) |
| ZA (1) | ZA826497B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2591595B1 (en) * | 1985-12-13 | 1988-09-09 | Roussel Uclaf | NOVEL 4-MORPHOLINYL 1H-INDOLE DERIVATIVES, SALTS THEREOF, PROCESS FOR THEIR PREPARATION, APPLICATION AS MEDICAMENTS, COMPOSITIONS CONTAINING THEM, AND INTERMEDIATES |
| EP0600675B1 (en) * | 1992-12-02 | 1998-07-08 | Kissei Pharmaceutical Co., Ltd. | Indoline compounds for the treatment of dysuria |
| FR2792313A1 (en) * | 1999-04-13 | 2000-10-20 | Synthelabo | 2-AMINOETHYL-INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1532210A (en) * | 1963-06-21 | 1968-07-12 | Ici Ltd | Heterocyclic compounds and their preparation process |
| FR2332010A1 (en) * | 1975-11-18 | 1977-06-17 | Continental Pharma | HETEROCYCLIC AMINO-ALCOHOL, ITS SALT AND ITS PREPARATION PROCESS |
-
1981
- 1981-09-17 FR FR8117560A patent/FR2512817A1/en active Granted
-
1982
- 1982-09-06 ZA ZA826497A patent/ZA826497B/en unknown
- 1982-09-13 EP EP82401660A patent/EP0076713B1/en not_active Expired
- 1982-09-13 DE DE8282401660T patent/DE3268423D1/en not_active Expired
- 1982-09-13 AT AT82401660T patent/ATE17347T1/en not_active IP Right Cessation
- 1982-09-15 PT PT75565A patent/PT75565B/en not_active IP Right Cessation
- 1982-09-16 HU HU822951A patent/HU189177B/en not_active IP Right Cessation
- 1982-09-16 FI FI823209A patent/FI77444C/en not_active IP Right Cessation
- 1982-09-16 DK DK413482A patent/DK413482A/en not_active Application Discontinuation
- 1982-09-16 AU AU88452/82A patent/AU550238B2/en not_active Ceased
- 1982-09-16 ES ES515755A patent/ES8401463A1/en not_active Expired
- 1982-09-16 IE IE2266/82A patent/IE54262B1/en not_active IP Right Cessation
- 1982-09-17 CA CA000411657A patent/CA1200554A/en not_active Expired
- 1982-09-17 JP JP57161090A patent/JPS5862161A/en active Pending
-
1983
- 1983-06-30 ES ES523718A patent/ES523718A0/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| PT75565A (en) | 1982-10-01 |
| JPS5862161A (en) | 1983-04-13 |
| ZA826497B (en) | 1983-07-27 |
| EP0076713B1 (en) | 1986-01-08 |
| FI77444C (en) | 1989-03-10 |
| ES8403869A1 (en) | 1984-04-01 |
| ES523718A0 (en) | 1984-04-01 |
| DE3268423D1 (en) | 1986-02-20 |
| DK413482A (en) | 1983-03-18 |
| CA1200554A (en) | 1986-02-11 |
| FI77444B (en) | 1988-11-30 |
| AU550238B2 (en) | 1986-03-13 |
| FR2512817B1 (en) | 1983-12-30 |
| PT75565B (en) | 1985-12-09 |
| ES515755A0 (en) | 1983-12-16 |
| IE54262B1 (en) | 1989-08-02 |
| HU189177B (en) | 1986-06-30 |
| ES8401463A1 (en) | 1983-12-16 |
| FR2512817A1 (en) | 1983-03-18 |
| FI823209L (en) | 1983-03-18 |
| FI823209A0 (en) | 1982-09-16 |
| EP0076713A1 (en) | 1983-04-13 |
| ATE17347T1 (en) | 1986-01-15 |
| IE822266L (en) | 1983-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK136191D0 (en) | 1H-imidazo / 4,5-c / quinoline derivative | |
| DE3362894D1 (en) | 1-3-dihydro 4-(1-hydroxy-2-amino-ethyl)-2h-indol-2-one derivatives, their salts, process for their preparation, their use as medicines and compositions containing them | |
| AU550238B2 (en) | Alpha-(aminomethyl) 1h-indol-4-methanol derivatives | |
| ES8703428A1 (en) | Composés amidés. | |
| ES8504681A1 (en) | 1-(2-Ethoxycarbonyl-4-phenylalkylamido)-3-amino-2-propanols, their preparations and their medicinal uses. | |
| HUT35253A (en) | Process for preparing 4-/3-alkynyl-oxy-2-hydroxy-propyl/-piperazin-1-y1-n-phenyl-acetamide derivatives | |
| ES8305372A1 (en) | Process for the preparation of 5,6,7,7a-tetrahydro-4H-thieno (3,2-c) pyridin-2-one derivatives. | |
| AU8694182A (en) | Process for the preparation of ursodesoxycholic acid | |
| DE69007203D1 (en) | Imidazole derivatives, process for their preparation and antiulcer agents containing them. | |
| ES274333A1 (en) | Procedure for the preparation of new compounds of 1,4-benzodioxane and 1,5-benzodioxepane (Machine-translation by Google Translate, not legally binding) | |
| GB1432736A (en) | Substituted 2-pyrones and process for their preparation | |
| YU150690A (en) | BENZOTHIAZINE DERIVATIVES AND PROCEDURE FOR THEIR OBTAINING | |
| ES446566A1 (en) | A procedure for the preparation of derivatives of 1-amino- (replaced) -3-4'-0-5'-tiazol (replaced) -2-oxi-2-propanol. (Machine-translation by Google Translate, not legally binding) | |
| DE68926016D1 (en) | Halogeno-4-methylpyrazoles and process for their preparation | |
| GB1380939A (en) | Piperidine compounds and use of piperidine compounds in the pre vention of premature vulcanization | |
| GB1110725A (en) | Process for preparing cyloheptimidazolinium halides | |
| ES383683A1 (en) | Coumarin derivatives and their use as optical brighteners | |
| ES333362A1 (en) | Procedure for the preparation of esters of the tiolphosphoric acid. (Machine-translation by Google Translate, not legally binding) | |
| ES327758A1 (en) | Procedure for the preparation of new derivatives of azepine. (Machine-translation by Google Translate, not legally binding) | |
| ES372259A3 (en) | Procedure for preparation of derivatives of s-triazol- (4.3 -a) pyridine. (Machine-translation by Google Translate, not legally binding) | |
| ES290000A1 (en) | Procedure for the preparation of carboxylic acid piperazides (Machine-translation by Google Translate, not legally binding) | |
| ES420606A1 (en) | Procedure for obtaining an ectoparasiticide composition. (Machine-translation by Google Translate, not legally binding) | |
| ES408560A1 (en) | Procedure for the obtaining of methanophosphonic acids. (Machine-translation by Google Translate, not legally binding) | |
| GB1128378A (en) | Novel alkene derivatives and processes for the preparation thereof |